カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の核酸治療薬CDMO市場（2023-2030）：種類別、サービス別（プロセス開発・最適化、製造サービス）、エンドユーザー別、用途別、地域別

【英語タイトル】Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type, By Service (Process Development & Optimization, Manufacturing Services), By End-user, By Application, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV219）・商品コード：GRV23NOV219
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

核酸治療薬CDMO市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の核酸治療薬CDMO市場規模は、2023年から2030年にかけて年平均成長率9.4%で推移し、2030年には224億2000万米ドルに達する見込みです。市場成長の主な要因は、核酸治療薬に対する需要の増加、核酸技術の進歩、核酸治療薬のFDA承認の増加などであり、費用対効果の高い受託開発・製造サービスのニーズが高まっています。

バイオテクノロジー企業、製薬会社、学術機関による遺伝子治療研究開発への投資と関心の高まりが、CDMOサービスの需要を促進しています。CDMOは遺伝子治療製造において重要な役割を果たしています。例えば、キャタレント社はサレプタ・セラピューティクス社の商業製造パートナーとして、遺伝子治療ソリューションを推進するための主要な役割を担っています。

COVID-19パンデミックへの対応におけるmRNAワクチンの成功は、核酸治療薬の可能性を示し、この分野へのさらなる研究と投資を刺激しました。例えば、サノフィは2022年3月、フランスにおけるメッセンジャーRNAワクチンの開発に今後数年間で10億2,000万米ドル（9億3,500万ユーロ）を充てる計画を発表しました。サノフィは、2021年6月に発表した20億ユーロ規模のグローバル投資イニシアチブの一環として、2026年までこの投資を行う予定です。このイニシアチブは、同社のmRNA戦略を促進するためのもの。このような資金調達シナリオの増加は、市場の成長を促進します。

さらに、CDMOの買収や提携の増加は、今後数年間、核酸治療薬CDMOの市場成長を加速させると予想されます。例えば、2022年5月、eureKARE社は、細胞・遺伝子治療受託開発製造機関（CDMO）を設立するため、1億6,098万米ドル（1億5,000万ユーロ）相当の合併を開始しました。

同社は、欧州の3つの開発・製造受託機関（CDMO）を統合することを目的に、特別目的買収会社（SPAC）であるeureKINGを設立しました。また、富士フイルムは2022年4月、カリフォルニア州にあるAtara Biotherapeutics, Inc.から細胞治療に特化した製造施設を取得することで、先端治療薬の開発・製造受託機関（CDMO）のポートフォリオを拡大しました。このような取り組みが市場の成長を後押しすると期待されています。

核酸治療薬CDMO市場レポートハイライト

- 2022年に最大の売上シェアを占めたのはRNAベースの治療薬セグメントです。RNAベースの治療薬（主にmRNA）は、様々な疾患に対応する汎用性を提供します。さまざまな治療用タンパク質を産生するように設計できるため、多様な治療領域に適用可能です。

- 遺伝子治療分野は、今後数年間で大きな市場成長が見込まれます。この背景には、遺伝子治療の臨床的成功があり、遺伝子治療の適応拡大に役立っています。

- 2022年には、製造サービス部門が市場を支配し、総収益シェアの38%以上を占めました。同分野の成長に寄与する主な要因としては、複雑な製造プロセス、スケールアップと生産に関する課題、コスト効率などが挙げられます。

- バイオテクノロジー企業は、革新的な治療法の研究開発に多額の投資を行っているため、2022年には58%以上の主要収益シェアを占めました。

- 用途別では、がん領域が2022年の売上高シェア31.0%超で世界市場をリードしました。この背景には、遺伝子治療やRNAベースの治療薬の採用が増加していること、また、がん領域向けの核酸治療薬のパイプラインが増加していることがあります。

- 2022年の核酸治療CDMO市場では、北米が38.49%の最大収益シェアを獲得しました。多額の投資と資金援助、強力な学術・研究機関、CDMOの世界的な拡大が地域の成長を促進しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の核酸治療薬CDMO市場：タイプ別予測・動向分析
第5章. 世界の核酸治療薬CDMO市場：サービス別予測・動向分析
第6章. 世界の核酸治療薬CDMO市場：エンドユーザー別予測・動向分析
第7章. 世界の核酸治療薬CDMO市場：用途別予測・動向分析
第8章. 世界の核酸治療薬CDMO市場：地域別予測・動向分析
第9章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.5. Market Driver Analysis
3.6. Market Restraint Analysis
3.7. Business Environment Analysis
3.7.1. SWOT Analysis
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Nucleic Acid Therapeutics CDMO Market: Type Movement Analysis
4.2. Gene Therapy
4.2.1. Gene Therapy Market, 2018 – 2030 (USD Billion)
4.3. RNA-based Therapies
4.3.1. RNA-based Therapies Market, 2018 – 2030 (USD Billion)
Chapter 5. Service Business Analysis
5.1. Nucleic Acid Therapeutics CDMO Market: Service Movement Analysis
5.2. Process Development and Optimization
5.2.1. Process Development and Optimization Market, 2018 – 2030 (USD Billion)
5.3. Manufacturing Services
5.3.1. Manufacturing Services Market, 2018 – 2030 (USD Billion)
5.4. Analytical and Quality Control Services
5.4.1. Analytical and Quality Control Services Market, 2018 – 2030 (USD Billion)
5.5. Others
5.5.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 6. End Users Business Analysis
6.1. Nucleic Acid Therapeutics CDMO Market: End Users Movement Analysis
6.2. Pharmaceutical Companies
6.2.1. Pharmaceutical Companies Market, 2018 – 2030 (USD Billion)
6.3. Government & Academic Research Institutes
6.3.1. Government & Academic Research Institutes Market, 2018 – 2030 (USD Billion)
6.4. Biotech Companies
6.4.1. Biotech Companies Market, 2018 – 2030 (USD Billion)
Chapter 7. Application Business Analysis
7.1. Nucleic Acid Therapeutics CDMO Market: Application Movement Analysis
7.2. Oncology
7.2.1. Oncology Market, 2018 – 2030 (USD Billion)
7.3. Genetic Disorders
7.3.1. Genetic Disorders Market, 2018 – 2030 (USD Billion)
7.4. Infectious Diseases
7.4.1. Infectious Diseases Market, 2018 – 2030 (USD Billion)
7.5. Others
7.5.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 8. Regional Business Analysis
8.1. Nucleic Acid Therapeutics CDMO Market Share by Region, 2022 & 2030
8.2. North America
8.2.1. North America Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Framework
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Framework
8.2.3.3. Competitive Scenario
8.2.3.4. Canada Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3. Europe
8.3.1. Europe Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. UK Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Germany Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. France Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Italy Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Spain Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Sweden Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.8. Norway
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Norway Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.9. Denmark
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Denmark Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Japan Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. China Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. India Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Australia Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. South Korea Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Thailand Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Brazil Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Mexico Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Argentina Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6. MEA
8.6.1. MEA Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. South Africa Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Saudi Arabia Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. UAE Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Kuwait Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Mergers & Acquisitions
9.2.2. Collaborations
9.2.3. New Product Launches
9.3. Participant’s overview
9.3.1. Catalent
9.3.1.1. Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Thermo Fisher Scientific
9.3.2.1. Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Lonza
9.3.3.1. Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. FUJIFILM Diosynth Biotechnologies
9.3.4.1. Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Cognate BioServices
9.3.5.1. Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Eurofins Genomics
9.3.6.1. Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Sirion Biotech
9.3.7.1. Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Oxford Biomedica
9.3.8.1. Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Danaher (Aldevron)
9.3.9.1. Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives

List of Tables

Table 1 List of data sources
Table 2 Global Nucleic Acid Therapeutics CDMO Market, by region, 2018 - 2030 (USD Billion)
Table 3 Global Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 4 Global Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 5 Global Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 6 Global Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 7 North America Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 8 North America Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 9 North America Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 10 North America Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 11 North America Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 12 U.S. Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 13 U.S. Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 14 U.S. Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 15 U.S. Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 16 Canada Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 17 Canada Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 18 Canada Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 19 Canada Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 20 Europe Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 21 Europe Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 22 Europe Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 23 Europe Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 24 Europe Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 25 UK Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 26 UK Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 27 UK Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 28 UK Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 29 Germany Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 30 Germany Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 31 Germany Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 32 Germany Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 33 France Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 34 France Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 35 France Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 36 France Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 37 Italy Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 38 Italy Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 39 Italy Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 40 Italy Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 41 Spain Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 42 Spain Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 43 Spain Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 44 Sapin Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 45 Denmark Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 46 Denmark Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 47 Denmark Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 48 Denmark Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 49 Sweden Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 50 Sweden Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 51 Sweden Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 52 Sweden Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 53 Norway Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 54 Norway Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 55 Norway Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 56 Norway Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 57 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 58 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 59 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 60 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 61 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 62 Japan Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 63 Japan Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 64 Japan Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 65 Japan Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 66 China Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 67 China Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 68 China Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 69 China Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 70 India Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 71 India Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 72 India Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 73 India Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 74 South Korea Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 75 South Korea Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 76 South Korea Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 77 South Korea Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 78 Australia Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 79 Australia Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 80 Australia Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 81 Australia Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 82 Thailand Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 83 Thailand Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 84 Thailand Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 85 Thailand Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 86 Latin America Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 87 Latin America Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 88 Latin America Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 89 Latin America Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 90 Latin America Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 91 Brazil Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 92 Brazil Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 93 Brazil Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 94 Brazil Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 95 Mexico Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 96 Mexico Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 97 Mexico Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 98 Mexico Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 99 Argentina Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 100 Argentina Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 101 Argentina Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 102 Argentina Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 103 MEA Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 104 MEA Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 105 MEA Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 106 MEA Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 107 MEA Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 108 South Africa Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 109 South Africa Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 110 South Africa Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 111 South Africa Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 112 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 113 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 114 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 115 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 116 UAE Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 117 UAE Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 118 UAE Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 119 UAE Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 120 Kuwait Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 121 Kuwait Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 122 Kuwait Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 123 Kuwait Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 124 Participant’s overview
Table 125 Financial performance
Table 126 Type benchmarking
Table 127 Strategic Initiatives

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment.
Fig. 7 Market formulation & validation
Fig. 8 Nucleic Acid Therapeutics CDMO Market revenue, 2018-2030 (USD Billion)
Fig. 9 Nucleic Acid Therapeutics CDMO Market Snapshot
Fig. 10 Nucleic Acid Therapeutics CDMO Market driver impact
Fig. 11 Nucleic Acid Therapeutics CDMO Market Restraint Impact
Fig. 12 Porter’s 5 Forces Analysis
Fig. 13 PESTEL Analysis
Fig. 14 Global Nucleic Acid Therapeutics CDMO Market: Type Movement Analysis
Fig. 15 Global Nucleic Acid Therapeutics CDMO Market: Type Key Takeaways
Fig. 16 Global Gene Therapy Market, 2018 - 2030 (USD Billion)
Fig. 17 Global RNA-based Therapies Market, 2018 - 2030 (USD Billion)
Fig. 18 Global Nucleic Acid Therapeutics CDMO Market: Service Movement Analysis
Fig. 19 Global Nucleic Acid Therapeutics CDMO Market: Service Key Takeaways
Fig. 20 Global Process Development and Optimization Market, 2018 - 2030 (USD Billion)
Fig. 21 Global Manufacturing Services Market, 2018 - 2030 (USD Billion)
Fig. 22 Global Analytical and Quality Control Services Market, 2018 - 2030 (USD Billion)
Fig. 23 Global Others Market, 2018 - 2030 (USD Billion)
Fig. 24 Global Nucleic Acid Therapeutics CDMO Market: End Users Movement Analysis
Fig. 25 Global Nucleic Acid Therapeutics CDMO Market: End Users Key Takeaways
Fig. 26 Pharmaceutical Companies Market, 2018 - 2030 (USD Billion)
Fig. 27 Government & Academic Research Institute Market, 2018 - 2030 (USD Billion)
Fig. 28 Biotech Companies Market, 2018 - 2030 (USD Billion)
Fig. 29 Global Nucleic Acid Therapeutics CDMO Market: Application Movement Analysis
Fig. 30 Global Nucleic Acid Therapeutics CDMO Market: Application Key Takeaways
Fig. 31 Oncology Market, 2018 - 2030 (USD Billion)
Fig. 32 Genetic Disorders Market, 2018 - 2030 (USD Billion)
Fig. 33 Infectious Diseases Market, 2018 - 2030 (USD Billion)
Fig. 34 Others Market, 2018 - 2030 (USD Billion)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 Regional Outlook, 2022 & 2030
Fig. 37 North America Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 38 U.S. Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 39 Canada Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 40 Europe Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 41 Germany Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 42 UK Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 43 France Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 44 Italy Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 45 Spain Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 46 Denmark Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 47 Norway Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 48 Sweden Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 49 Asia Pacific Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 50 Japan Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 51 China Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 52 India Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 53 Australia Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 54 South Korea Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 55 Thailand Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 56 Latin America Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 57 Brazil Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 58 Mexico Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 59 Argentina Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 60 Middle East and Africa Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 61 South Africa Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 62 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 63 UAE Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 64 Kuwait Nucleic Acid Therapeutics CDMO Market, 2018 - 2030 (USD Billion)
Fig. 65 Market participant categorization
Fig. 66 Heat map analysis

★調査レポート[世界の核酸治療薬CDMO市場（2023-2030）：種類別、サービス別（プロセス開発・最適化、製造サービス）、エンドユーザー別、用途別、地域別] (コード：GRV23NOV219)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の核酸治療薬CDMO市場（2023-2030）：種類別、サービス別（プロセス開発・最適化、製造サービス）、エンドユーザー別、用途別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のバーチャルイベント市場（2023-2030）：イベント種類別、サービス別、施設規模別、エンドユーザー別、用途別、産業別、使用例別、地域別
  • 世界の腫瘍コンパニオン診断市場（2023-2030）：製品・サービス別、技術別（IHC、NGS）、疾患種類別（乳がん、白血病）、エンドユーザー別、地域別
  • 世界のスマートビルディング市場（2023-2030）：ソリューション別（安全・セキュリティ管理、エネルギー管理）、サービス別（コンサルティング、インプリメンテーション）、エンドユーザー別、地域別
  • 世界のバイオプロセスバッグ市場2023-2030：種類別（2Dバイオプロセスバッグ、3Dバイオプロセスバッグ、その他バッグ＆付属品）、ワークフロー別（上流工程、下流工程、プロセス開発）、エンドユーザー別（製薬＆バイオ医薬品企業、CMO＆CRO、学術＆研究機関）、地域別
  • 世界の予知保全市場（2023-2030）：コンポーネント別、ソリューション別、サービス別、展開方法別、企業規模別、モニタリング技術別、最終用途別、地域別
  • 世界の核酸増幅検査市場（2023-2030）：種類別（PCR、INAAT）、用途別（感染症検査、がん検査）、エンドユーザー別、地域別
  • 世界のラットモデル市場（2023-2030）：種類別（交配種、ノックアウト）、技術別（胚性幹細胞、マイクロインジェクション）、サービス別、用途別、最終用途別、地域別
  • 世界の希少バイオマーカー検体採取＆安定化市場（2023-2030）：バイオマーカー別、エンドユーザー別（研究、診断）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆